SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

July 29, 2011 08:35 ET

MMRGlobal Announces Exclusive Webcast and Television Interview on MoneyTV With MMRF Spokesperson Kira Reed and First-Ever Academy Award® Best Actor Nominee Rin Tin Tin

Rin Tin Tin to Help Call Attention to American Humane Association and the Importance of Personal Health Records for the Entire Family, Including Pets, Airing in 170 Million Homes in 75+ Countries Worldwide

LOS ANGELES, CA--(Marketwire - Jul 29, 2011) - Kira Reed, spokesperson for MMRGlobal, Inc. (OTCBB: MMRF), will appear on "MoneyTV with Rin Tin Tin and Donald Baillargeon" on Friday, July 29th to discuss the opportunity for investors in health IT, particularly Personal Health Records (PHR).

MMRGlobal offers a suite of health IT products and services, including the MyMedicalRecords.com Personal Health Record (PHR) (www.mmrvideos.com) for consumers, healthcare professionals, employers, insurance companies, financial institutions, affinity groups and professional organizations, and MMRPro for physicians, small hospitals and surgery centers. Kira Reed will appear with famous canine and heroic rescue dog "Rin Tin Tin," who received the most votes as best actor at the first Academy Awards®. The Company is negotiating with Rin Tin Tin as a spokesdog to emphasize how its multilingual MyMedicalRecords PHR is already designed to include pets.

Ms. Reed will also comment on details of the Company's recent joint press release with Kodak earlier this week announcing the signing of a definitive purchase agreement for an MMRGlobal customized private label version of Kodak's Scan Station Pro 550 as part of its MMRPro solution.

"MoneyTV with Donald Baillargeon" is internationally syndicated in more than 170 million homes worldwide and is available in more than 70 million homes in the U.S. The television program is all about money and features informative interviews with company CEOs on trends affecting their business and outlooks for the future. The weekly television program first aired in 1996.

About MoneyTV:

MoneyTV is also broadcast on UPN-TV in the Virgin Islands and Puerto Rico.

MoneyTV airs eight times per week in the 21 Caribbean Territories on CaribVision Network.

MoneyTV is broadcast to 48 million TV homes in Western Europe on BEN TV Network and OBE-TV.

MoneyTV is also available in Asia on the Familyland TV Network.

A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net.

MoneyTV Executive Producer and Anchor Don Baillargeon is also the host of the radio program MoneyRap Radio, http://www.moneyrap.com, and the television program Health This Week, http://www.healththisweek.com.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMR Global, Inc. and its products, visit http://www.mmrglobal.com/

MoneyTV Disclaimer

MoneyTV television program, Copyright MMXI, all rights reserved. MoneyTV does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,500.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producers, publisher or parent company of MoneyTV.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; media appearances, scheduling and coverage; ongoing negotiations for talent; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Source for Rin Tin Tin and the Academy Awards®: "Rin Tin Tin: The Life and The Legend" by Susan Orlean cited in ReadRollShow.com.

Contact Information